COVID-ONE-humoral immune: The One-stop Database for COVID-19-specific Antibody Responses and Clinical Parameters
Z. Xu, Y. Li, Q. Lei, L. Huang, D.-y. Lai, S.-j. Guo, H.-w. Jiang, H. Hou, Y.-x. Zheng, X.-n. Wang, J. Wu, M.-l. Ma, B. Zhang, H. Chen, C. Yu, J.-b. Xue, H.-n. Zhang, H. Qi, S. Yu, M. Lin, Y. Zhang, X. Lin, Z. Yao, H. Sheng, Z. Sun, , S.-c. Tao
Abstract
Coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2, varies with regard to symptoms and mortality rates among populations. Humoral immunity plays critical roles in SARS-CoV-2 infection and recovery from COVID-19. However, differences in immune responses and clinical features among COVID-19 patients remain largely unknown. Here, we report a database for COVID-19-specific IgG/IgM immune responses and clinical parameters (COVID-ONE humoral immune). COVID-ONE humoral immunity is based on a dataset that contains the IgG/IgM responses to 21 of 28 known SARS-CoV-2 proteins and 197 spike protein peptides against 2,360 COVID-19 samples collected from 783 patients. In addition, 96 clinical parameters for the 2,360 samples and information for the 783 patients are integrated into the database. Furthermore, COVID-ONE humoral immune provides a dashboard for defining samples and a one-click analysis pipeline for a single group or paired groups. A set of samples of interest is easily defined by adjusting the scale bars of a variety of parameters. After the "START" button is clicked, one can readily obtain a comprehensive analysis report for further interpretation. COVID-ONE-humoral immune is freely available at www.COVID-ONE.cn.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Expansion of SARS-CoV-2-specific Antibody-secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients
R. Varnaite, M. Garcia, … S. Gredmark-Russ·bioRxiv·May 28, 2020
- Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike
J. Prevost, R. Gasser, … A. Finzi·bioRxiv·Jun 8, 2020
- Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19
A. E. Oja, A. Saris, … P. Hombrink·bioRxiv·Jun 18, 2020
- Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
C. Li, D. Yu, … X. Yang·Nature CommunicationsPeer-reviewed·Jul 6, 2021
- Occurrence of COVID-19 symptoms during SARS-CoV-2 infection defines waning of humoral immunity
- Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India
K. Nayak, K. Gottimukkala, … A. Chandele·bioRxiv·Aug 31, 2020